Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dosing of Various Multi Kinases Inhibitors Plasma Concentrations for Patients Treated for Their Advanced Digestive Cancer, With the Aim to Determine the Best Optimal Dose for Each Treatment, in the Future

NCT05443087 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT05443087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05443087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dosing of Various Multi Kinases Inhibitors Plasma Concentrations for Patients Treated for Their Advanced Digestive Cancer, With the Aim to Determine the Best Optimal Dose for Each Treatment, in the Future
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Recruiting
Start date
August 29, 2022
Completion date
June 30, 2027
Enrollment
330 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

digestive cancer, gist, hepatocellular carcinoma, metastatic colorectal cancer, neuroendocrine tumors